Drug resistance in Schistosomiasis: a review

• Main Authors: John I. Bruce, Luiz Candido de Souza Dias, Liang Yung-San, Gerald C. Coles
• Format: Article
• Language: English
• Published: Instituto Oswaldo Cruz, Ministério da Saúde 1987-01-01
• Series: Memórias do Instituto Oswaldo Cruz.
• Online Access: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761987000800025
• ISSN: 0074-0276; 1678-8060

Drug resistance associated with the treatment of human schistosomiasis appears to be an emerging problem requiring more attention from the scientific community than the subject currently receives. Drug-resistant strains of Schistosoma mansoni have been isolated by various investigators as a result of laboratory experimentation or from a combination of field and laboratory studies. Review of this data appears to indicate that the lack of susceptibility observed for some of the isolated strains cannot be ascribed solely to previous administration of antischistosome drugs and thus further studies are required to elucidate this phenomena. Strains of S. mansoni have now been identified from Brazil which are resistant to oxamniquine, hycanthone and niridazole; from Puerto Rico which are resistant to hycanthone and oxamniquine; and from Kenya which are resistant to niridazole and probably oxamniquine. Strains derived by in vitro selection and resistant to oxamniquine and possibly to oltipraz are also available. All of these strains are currently maintained in the laboratory in snails and mice, thus providing for the first time an opportunity for indepth comparative studies. Preliminary data indicates that S. haematobium strains resistant to metrifonate may be occurring in Kenya. This problem could poise great difficulty in the eventual development of antischistosomal agents. Biomphalaria glabrata from Puerto Rico and Brazil were found to be susceptible to drug-resistant S. mansoni from each country.